Sophie Poitou
About Sophie Poitou
Sophie Poitou is a Regulatory Affairs Specialist III at Nektar Therapeutics, where she has worked since 2018. She has a diverse background in regulatory affairs and clinical trial operations, with previous roles at Ipsen, Voisin Consulting Life Sciences, Menarini Group, and Genentech.
Current Role at Nektar Therapeutics
Sophie Poitou has been employed at Nektar Therapeutics since 2018, serving as a Regulatory Affairs Specialist III. In this role, she is responsible for ensuring compliance with regulatory requirements and facilitating the approval process for pharmaceutical products. Her expertise in regulatory affairs plays a critical role in the development and commercialization of new therapies.
Previous Experience in Regulatory Affairs
Before joining Nektar Therapeutics, Sophie Poitou worked at Voisin Consulting Life Sciences (VCLS) from 2015 to 2017 as a Regulatory Scientist focusing on clinical trial operations. She also held positions at Ipsen as a Regulatory Affairs Intern in 2012 and as a Student Employee in 2007. Additionally, she worked at Genentech as a Regulatory Affairs Intern from 2014 to 2015, where she contributed to program management and strategic labeling.
Internship and Early Career Background
Sophie Poitou's early career includes an internship at Menarini Group in 2013, where she focused on market access and business development for five months. She also worked as a Student Employee at Société Générale from 2009 to 2011, gaining valuable experience in a corporate environment. Her diverse internships provided a foundation for her career in regulatory affairs.
Education and Academic Qualifications
Sophie Poitou holds a Doctorate in Pharmacy from Paris-Sud University (Paris XI), which she completed between 2007 and 2014. She also achieved a Master's degree from the same institution from 2013 to 2014. Her academic background in pharmacy has equipped her with the knowledge necessary for her regulatory roles in the pharmaceutical industry.